InvestorEmpowering Arizona's startups through innovation and funding.
Life Sciences Greenhouse Investments
Life Sciences Greenhouse Investments (LSGI) is an evergreen venture fund based in Harrisburg, Pennsylvania, focused on early-stage life science companies. It aims to bridge the funding gap between pre-seed and Series B stages while enhancing healthcare outcomes.
Online destinations
Find Life Sciences Greenhouse Investments online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
Life Sciences Greenhouse Investments (LSGI) was established in 2002 through Pennsylvania legislation that allocated funds from the Master Tobacco Settlement Act. The fund is dedicated to strengthening the life sciences ecosystem in Pennsylvania and improving global healthcare outcomes. LSGI provides early-stage capital and operational expertise to life science companies, typically investing between $250,000 and $1.5 million. The organization focuses on drug discovery, diagnostics, and medical devices, aiming to support the commercialization of innovative healthcare solutions. Since its inception, LSGI has invested $44 million in 86 companies, contributing to the creation and retention of over 1,850 jobs in the state.
Focus
LSGI invests in early-stage life science companies, particularly those involved in drug discovery, diagnostics, and medical devices. The organization aims to bridge the funding gap between pre-seed and Series B stages, offering business and scientific advice to support the commercialization of innovative healthcare solutions.
Support
LSGI adds value to its portfolio companies by providing not only capital but also operational support and expertise in navigating the complexities of the life sciences sector. This includes business and scientific advice to help companies commercialize their innovative healthcare solutions effectively.
Questions
What are the investment criteria for LSGI?
LSGI focuses on early-stage life science companies involved in drug discovery, diagnostics, and medical devices. The fund typically invests between $250,000 and $1.5 million, aiming to bridge the funding gap between pre-seed and Series B stages.
How can I apply or pitch to LSGI?
Founders can pitch to LSGI through their website at lsgpa.com/contact or by emailing admin@LSGPA.com. It is advisable to include a detailed business plan and information about the team and product.
What makes LSGI different from other venture funds?
LSGI not only provides capital but also offers operational support and scientific expertise to help portfolio companies navigate the complexities of the life sciences sector. This dual approach enhances the likelihood of successful commercialization.
What is LSGI's geographic focus?
LSGI primarily invests in companies based in Pennsylvania, aligning with its mission to strengthen the local life sciences ecosystem while also improving healthcare outcomes globally.
What is the fund size and check size range?
LSGI has a total fund size of $44 million and typically invests between $250,000 and $1.5 million in each company.
What kind of post-investment involvement does LSGI have?
LSGI is actively involved with its portfolio companies, providing ongoing operational support and strategic guidance to help them achieve their commercialization goals.
Check your startup’s fit
Check your startup’s fit with Life Sciences Greenhouse InvestmentsSimilar investors
Organizations that do similar work to Life Sciences Greenhouse Investments.
Investor
InvestorBen Franklin Technology Partners (BFTP) is a Pennsylvania-based nonprofit organization focused on fostering innovation and economic growth through investments in technology-based companies. It operates as a quasi-public seed investor and hybrid accelerator across four regional centers in the state.
InvestorBioGenerator Ventures is an early-stage venture capital firm based in St. Louis, Missouri, focusing on life sciences investments in healthcare and agriculture. It operates as the investment arm of BioSTL, providing catalytic capital and resources to support startups.
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works